DEA Targets Synthetic 7-OH Products With Schedule I Proposal
The Drug Enforcement Administration (DEA) has taken a major step toward placing concentrated 7-hydroxymitragynine (7-OH) products under Schedule I of the Controlled Substances Act (CSA), while exempting natural leaf kratom that does not contain enhanced …